Liu J, Miao X, Xiao B, Huang J, Tao X, Zhang J, et al. Obg-Like ATPase 1 Enhances Chemoresistance of Breast Cancer via Activation of TGF-β/Smad Axis Cascades. Front Pharmacol. 2020;11:666 pubmed 出版商

Jiao M, Ning S, Chen J, Chen L, Jiao M, Cui Z, et al. Long non‑coding RNA ZEB1‑AS1 predicts a poor prognosis and promotes cancer progression through the miR‑200a/ZEB1 signaling pathway in intrahepatic cholangiocarcinoma. Int J Oncol. 2020;56:1455-1467 pubmed 出版商

Di Cosimo S, La Verde N, Moretti A, Cazzaniga M, Generali D, Bianchi G, et al. Neoadjuvant eribulin mesylate following anthracycline and taxane in triple negative breast cancer: Results from the HOPE study. PLoS ONE. 2019;14:e0220644 pubmed 出版商

Yin Y, Liu W, Shen Q, Zhang P, Wang L, Tao R, et al. The DNA endonuclease Mus81 regulates ZEB1 expression and serves as a target of BET4 inhibitors in gastric cancer. Mol Cancer Ther. 2019;: pubmed 出版商

Qin Y, Yu J, Zhang M, Qin F, Lan X. ZEB1 promotes tumorigenesis and metastasis in hepatocellular carcinoma by regulating the expression of vimentin. Mol Med Rep. 2019;19:2297-2306 pubmed 出版商

Jiang G, Shi W, Fang H, Zhang X. miR‑27a promotes human breast cancer cell migration by inducing EMT in a FBXW7‑dependent manner. Mol Med Rep. 2018;18:5417-5426 pubmed 出版商

Xu X, Bao Z, Liu Y, Jiang K, Zhi T, Wang D, et al. PBX3/MEK/ERK1/2/LIN28/let-7b positive feedback loop enhances mesenchymal phenotype to promote glioblastoma migration and invasion. J Exp Clin Cancer Res. 2018;37:158 pubmed 出版商

Wang X, Hou Q, Zhou X. LAMA4 expression is activated by zinc finger E‑box‑binding homeobox 1 and independently predicts poor overall survival in gastric cancer. Oncol Rep. 2018;40:1725-1733 pubmed 出版商

Heredia Soto V, Redondo A, Berjón A, Miguel Martín M, Diaz E, Crespo R, et al. High-throughput 3-dimensional culture of epithelial ovarian cancer cells as preclinical model of disease. Oncotarget. 2018;9:21893-21903 pubmed 出版商

Francis J, Capper A, Ning J, Knight E, de Bono J, Swain A. SOX9 is a driver of aggressive prostate cancer by promoting invasion, cell fate and cytoskeleton alterations and epithelial to mesenchymal transition. Oncotarget. 2018;9:7604-7615 pubmed 出版商

Zu C, Liu S, Cao W, Liu Z, Qiang H, Li Y, et al. MiR-590-3p suppresses epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma by inhibiting SIP1 expression. Oncotarget. 2017;8:34698-34708 pubmed 出版商

Deng S, Li X, Niu Y, Zhu S, Jin Y, Deng S, et al. MiR-652 inhibits acidic microenvironment-induced epithelial-mesenchymal transition of pancreatic cancer cells by targeting ZEB1. Oncotarget. 2015;6:39661-75 pubmed 出版商

Piskareva O, Harvey H, Nolan J, Conlon R, Alcock L, Buckley P, et al. The development of cisplatin resistance in neuroblastoma is accompanied by epithelial to mesenchymal transition in vitro. Cancer Lett. 2015;364:142-55 pubmed 出版商

Shi S, Wang L, Yu B, Li Y, Jin Y, Bai X. LncRNA-ATB promotes trastuzumab resistance and invasion-metastasis cascade in breast cancer. Oncotarget. 2015;6:11652-63 pubmed